CClinicalTrials.gg
Sign In
Status unknownNCT02890004ProReSHAUpdated Feb 23, 2018

Observational Study of Patients With Subarachnoid Hemorrhage

An observational study in Subarachnoid Hemorrhage, sponsored by Hospices Civils de Lyon. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-23.

Sponsored by Hospices Civils de Lyon · Observational

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

This prospective, observational study aim to identify :

  • Prognostic factor of patients with subarachnoid haemorrhage in neuro intensive care unit
  • The impact of standard therapeutic used (surgery, embolization ; medical treatment of vasospasm ; treatment of complications like hyponatremia, stress myocardiopathy, ...)
02

Conditions studied

  • Subarachnoid Hemorrhage

Keywords

  • Subarachnoid Hemorrhage
  • Neurointensive care
  • Observational registry
03

In context

Subarachnoid Hemorrhage

509 studies on the registry are indexed under Subarachnoid Hemorrhage; 124 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 117 across 226 observational studies indexed under Subarachnoid Hemorrhage.

Browse Subarachnoid Hemorrhage studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients admitted to the unit of investigator with subarachnoid hemorrhage, whatever the etiology, is included in their prospective registry

Inclusion criteria

  • Subarachnoid hemorrhage

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Survival

    Time frame: at day 0

  2. Survival

    Time frame: at 6 months

  3. Survival

    Time frame: at 12 months

Secondary outcomes

  1. Neurological outcome with the Glasgow Coma Scale (GCS) score

    Time frame: at day 0

  2. Neurological outcome with the Glasgow Coma Scale (GCS) score

    Time frame: at 6 months

  3. Neurological outcome with the Glasgow Coma Scale (GCS) score

    Time frame: at 12 months

  4. Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score

    Time frame: at day 0

  5. Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score

    Time frame: at 6 months

  6. Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score

    Time frame: at 12 months

  7. Brain lesions with MRI

    Time frame: at day 0

  8. Brain lesions with MRI

    Time frame: at 6 months

  9. Brain lesions with MRI

    Time frame: at 12 months

  10. delay of apparition of hyponatremia

    Natremia in standard blood sample, Natremia is routinelly evaluated on alternte days, and more if required.

    Time frame: on alternte days after Day 0

07

Study locations

1 of 1 sites recruiting
  • Service de réanimation polyvalente neurologique Hôpital Neurologique HCL
    Bron, 69500, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02890004
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Sep 7, 2016
Start date
Feb 16, 2017
Primary completion
Mar 16, 2020 (estimated)
Completion
Mar 16, 2020 (estimated)
Last update
Feb 23, 2018

Study contacts

Frédéric DAILLER, MD
Contact
frederic.dailler@chu-lyon.fr
4 72 35 75 76 ext. +33
Frédéric DAILLER, MD
principal investigator · Service de réanimation neurologique Hospices Civils de Lyon

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Subarachnoid Hemorrhage→

Other studies from this sponsor

Hospices Civils de Lyon

Start the discussion